Key result
Flecainide acetate, a fluorinated local anesthetic analogue of procainamide synthesized in 1972, has recently become available as an oral agent for the management of ventricular arrhythmias.
Population
Patients with ventricular arrhythmias
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Flecainide now offers an oral option for ventricular arrhythmias; leaves open questions on long-term safety and comparative efficacy.
Structured PICO
P
Population
Patients with ventricular arrhythmias
I
Intervention
Flecainide acetate (oral)
Flecainide acetate is an oral antiarrhythmic agent recently approved in the United States for the management of ventricular arrhythmias.
Cite This Study
Roden et al. (1986) conducted a review in Ventricular arrhythmias. Flecainide acetate was evaluated. Flecainide acetate, a fluorinated local anesthetic analogue of procainamide synthesized in 1972, has recently become available as an oral agent for the management of ventricular arrhythmias.